Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LUKCHAI BHAVABHUTANON

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1922032952
CMS profile
87508
Location
MONTEREY PARK, CA

General Payments · PY2018–2024

$2,922.77

  • Reported across 124 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$575.76

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $575.76 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $261.71 5
Boehringer Ingelheim Pharmaceuticals, Inc. $124.99 1
Novo Nordisk AS $106.49 5
Ardelyx, Inc. $82.57 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $716.82 40
PY2019 $864.56 45
PY2020 $171.36 10
PY2021 $27.76 2
PY2022 $298.09 6
PY2023 $268.42 7
PY2024 $575.76 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Ardelyx, Inc. $32.91 01/24/2024 Food and Beverage Undisputed 01/23/2026 1146671679 CMS
Ardelyx, Inc. $23.18 06/13/2024 Food and Beverage Undisputed 01/23/2026 1146671681 CMS
Ardelyx, Inc. $26.48 08/19/2024 Food and Beverage Undisputed 01/23/2026 1146671683 CMS
AstraZeneca Pharmaceuticals LP $123.45 01/17/2024 Food and Beverage Undisputed 01/23/2026 1105406761 CMS
AstraZeneca Pharmaceuticals LP $92.66 01/30/2024 Food and Beverage Undisputed 01/23/2026 1105286615 CMS
AstraZeneca Pharmaceuticals LP $14.13 09/19/2024 Food and Beverage Undisputed 01/23/2026 1104481662 CMS
AstraZeneca Pharmaceuticals LP $13.94 10/09/2024 Food and Beverage Undisputed 01/23/2026 1105551836 CMS
AstraZeneca Pharmaceuticals LP $17.53 12/05/2024 Food and Beverage Undisputed 01/23/2026 1104655817 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $124.99 03/07/2024 Food and Beverage Undisputed 01/23/2026 1118235111 CMS
Novo Nordisk Inc $20.75 02/01/2024 Food and Beverage Undisputed 01/23/2026 1097146761 CMS
Novo Nordisk Inc $20.32 06/14/2024 Food and Beverage Undisputed 01/23/2026 1097736115 CMS
Novo Nordisk Inc $23.03 08/27/2024 Food and Beverage Undisputed 01/23/2026 1097381877 CMS
Novo Nordisk Inc $21.58 10/21/2024 Food and Beverage Undisputed 01/23/2026 1097732721 CMS
Novo Nordisk Inc $20.81 11/21/2024 Food and Beverage Undisputed 01/23/2026 1096916396 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.